扩张型心肌病
心悸
心力衰竭
心肌病
心脏病学
医学
内科学
病毒性心肌炎
冠状动脉疾病
免疫抑制
心肌炎
作者
Sandeep Sagar,Peter P. Liu,Leslie T. Cooper
出处
期刊:The Lancet
[Elsevier]
日期:2011-12-18
卷期号:379 (9817): 738-747
被引量:600
标识
DOI:10.1016/s0140-6736(11)60648-x
摘要
Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease. The short-term prognosis of acute myocarditis is usually good, but varies widely by cause. Those patients who initially recover might develop recurrent dilated cardiomyopathy and heart failure, sometimes years later. Because myocarditis presents with non-specific symptoms including chest pain, dyspnoea, and palpitations, it often mimics more common disorders such as coronary artery disease. In some patients, cardiac MRI and endomyocardial biopsy can help identify myocarditis, predict risk of cardiovascular events, and guide treatment. Finding effective therapies has been challenging because the pathogenesis of chronic dilated cardiomyopathy after viral myocarditis is complex and determined by host and viral genetics as well as environmental factors. Findings from recent clinical trials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical course despite standard medical care and might improve with a short course of immunosuppression.
科研通智能强力驱动
Strongly Powered by AbleSci AI